(Q39166000)

English

Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome

scientific article published on 16 October 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome (English)

1 reference

Europe PubMed Central

9 September 2017

0 references

4

object named as

J Valeur

1 reference

Europe PubMed Central

9 September 2017

2

object named as

T Hausken

1 reference

Europe PubMed Central

9 September 2017

Jan Gunnar Hatlebakk

6

object named as

J G Hatlebakk

1 reference

Europe PubMed Central

9 September 2017

Karl Albert Brokstad

5

object named as

K Brokstad

1 reference

Europe PubMed Central

9 September 2017

author name string

T N Hustoft

1

1 reference

Europe PubMed Central

9 September 2017

S O Ystad

3

1 reference

Europe PubMed Central

9 September 2017

G A Lied

7

1 reference

Europe PubMed Central

9 September 2017

publication date

16 October 2016

1 reference

Europe PubMed Central

9 September 2017

Neurogastroenterology and Motility

1 reference

Europe PubMed Central

9 September 2017

29

1 reference

Europe PubMed Central

9 September 2017

4

1 reference

Europe PubMed Central

9 September 2017

Irritable bowel syndrome: a clinical review.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Irritable bowel syndrome: a clinical review

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Food intolerance in functional bowel disorders

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Short-chain carbohydrates and functional gastrointestinal disorders.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Diet in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Irritable bowel syndrome, gut microbiota and probiotics.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Prebiotic effects: metabolic and health benefits

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

β2-1 Fructan supplementation alters host immune responses in a manner consistent with increased exposure to microbial components: results from a double-blinded, randomised, cross-over study in healthy adults.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

The effects of butyrate enemas on visceral perception in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Colonic butyrate- algesic or analgesic?

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Cytokines and irritable bowel syndrome: where do we stand?

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity.

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Indication of immune activation in patients with perceived food hypersensitivity

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Gut microbiota and inflammation

1 reference

https://api.crossref.org/works/10.1111%2FNMO.12969

21 January 2018

Identifiers

10.1111/NMO.12969

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39166000&oldid=1811539165"